BATS BZX Real-Time Price
As of 3:50pm ET
| +0.08 / +5.30%|
The 4 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 5.25, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +230.19% increase from the last price of 1.59.
The current consensus among 4 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.